WHAT WE’RE READING- JOURNAL CLUB

May 2024

Tranexamic Acid Verus Placebo in Individuals with Intracerebral Hemorrhage Treated within 2 H of Symptom Onset (STOP-MSU): An International, Double-Blind, Randomized, Phase 2 Trail
Tenecteplase Verses Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): A Randomized Open Label, Phase 3 Superiority Trail